Lv1
40 积分 2024-06-30 加入
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
19天前
已完结
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study
21天前
已完结
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
21天前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
25天前
已完结
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
29天前
已完结
Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer
1个月前
已完结
Response criteria for the prostate of the USA national prostatic cancer project
4个月前
已完结
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
4个月前
已完结
Prognostic significance of involvement of the circumferential resection margin/surface in patients with pancreatic head cancer: a prospective evaluation of pancreatoduodenectomy specimens using the 0 and 1 mm rules
5个月前
已完结
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
6个月前
已完结
皖公网安备34019202002308
